Navigation Links
Opportunities for Funding US-Israel Cooperation in Innovative Technologies
Date:7/27/2011

TEL AVIV, Israel, July 27, 2011 /PRNewswire/ --

 

The Next Call for Proposals has Been Issued by the BIRD Foundation. Relevant R&D Topics Include but not Limited to: Life Sciences, Cleantech, Communications, Electronics, Software, HLS, etc.

The BIRD Foundation announced its next funding cycle with a call for US-Israel joint project proposals focusing on innovative R&D collaborations between US and Israeli companies. To be considered, a proposal should have significant commercial potential.

The maximum conditional grant per project is up to 50% of the R&D costs associated with the joint project, and no more than $1 million per project.

The application process is web-based and requires prior discussion with the BIRD Foundation.  Executive Summaries are due by Thursday, September 15, 2011. Final full scale proposals are due by Thursday, October 26, 2011. Decisions will be announced by mid December, 2011. Please refer to BIRD's website for submission details - http://www.birdf.com.

Examples of successful BIRD-funded projects include:

ReWalk - Helping Paraplegics to Walk: With support from the BIRD Foundation, Argo Medical Technologies and Allied Orthotics & Prosthetics are working together to develop the ReWalk device that allows a paralyzed patient to "walk" again.

Mobile Travel Tool: MobiMate, a provider of mobile travel services, partnered with Conducive Technology, to develop its newest mobile travel tool, WorldMate Live which predicts travel conflicts for road warriors and automatically provides solutions, often before a traveler even knows there is a potential problem.

New Drug for Gout: KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients that are refractory to conventional therapy. The drug has been developed by Mountain View Pharmaceuticals, and Bio-technology General (acquired by Savient Pharmaceuticals) and approved by the U.S. Food and Drug Administration.

About the BIRD Foundation

The BIRD (Binational Industrial Research and Development) Foundation works to encourage cooperation between Israeli and American companies in the various areas of technology, and provides free assistance in locating strategic partners from both countries for developing joint products. During its 34 years, the BIRD Foundation has invested in more than 820 projects, which have yielded direct and indirect revenues of about $8 billion.

The BIRD Foundation supports projects without receiving any rights in the participating companies or in the project itself. The financial assistance is repaid as royalties from sales. The Foundation provides support of up to 50% of a project's budget, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation shares the risk and does not demand that the investment be repaid if the project fails to reach the sales stage.

The BIRD Foundation works in full cooperation with the Chief Scientist's Office at the Ministry of Industry, Trade, and Labor in Israel, and with the U.S. Commerce Department's National Institute of Standards and Technology (NIST).

For further inquiries:
Palo Alto, CA - Michal Miasnik, West Coast Representative
Tel: +1-408-398-1288 / michalm@birdf.com
Princeton, NJ - Andrea Yonah East, Coast Representative
Tel: +1-609-356-0305 / andreay@birdf.com

http://www.birdf.com



'/>"/>
SOURCE The BIRD Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
2. Maximizing Pharmaceutical Licensing Opportunities
3. Global Pharmaceutical Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Buyer Spend and Procurement Strategies
4. Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
5. Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
6. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
7. Reportlinker Adds Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
8. Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands
9. 2011 Retail Clinician Education Congress to Offer Exclusive Accreditation and Networking Opportunities for Retail Healthcare Professionals
10. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
11. Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") ... Surgical facility in Las Piedras, Puerto Rico ... and blades. ... the facility sustained minor structural damage, temporary loss of ... Repairs have been completed, manufacturing operations have resumed, and ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):